D. Bikard, et al. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Research. 2013 June 12. doi: 10.1093/nar/gkt520.

Mar

20

Editas Medicine Announces Chief Financial Officer Transition

Mar

5

Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates

Feb

24

Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March